We previously reported that treatment with small-molecule PIM inhibitors significantly reduces metastasis in orthotopic models of prostate and colon cancer (Casillas et al., 2018), but the mechanisms responsible have not been established. This evidence concerns the gene PIM1 and malignant colon neoplasm.